Veritable’s iShares Global Healthcare ETF IXJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-6,003
Closed -$500K 908
2023
Q1
$500K Buy
6,003
+609
+11% +$50.5K 0.01% 536
2022
Q4
$458K Sell
5,394
-459
-8% -$37.9K 0.01% 556
2022
Q3
$441K Sell
5,853
-321
-5% -$26K 0.01% 535
2022
Q2
$501K Sell
6,174
-965
-14% -$80.7K 0.01% 542
2022
Q1
$626K Sell
7,139
-1,895
-21% -$160K 0.01% 505
2021
Q4
$816K Hold
9,034
0.01% 444
2021
Q3
$756K Sell
9,034
-299
-3% -$25.9K 0.01% 448
2021
Q2
$776K Buy
9,333
+2,404
+35% +$194K 0.01% 435
2021
Q1
$534K Buy
+6,929
New +$533K 0.01% 496

Other funds holding IXJ

Veritable's IXJ Position: Q2 2023 in Review

Veritable sold out of iShares Global Healthcare ETF (IXJ) in Q2 2023, closing a stake of 6,003 shares — an estimated $500K sold.

Veritable first reported a position in IXJ in Q1 2021 and held it in 9 quarters. The position peaked at $816K in Q4 2021. 271 funds tracked by Wall St. Rank hold IXJ as of Q2 2023.

  • Veritable reported no remaining iShares Global Healthcare ETF position as of Q2 2023 after selling out during the quarter.
  • Veritable sold 6,003 iShares Global Healthcare ETF shares in Q2 2023, an estimated $500K.
  • Veritable first reported a position in iShares Global Healthcare ETF in Q1 2021 and held it in 9 quarters.
  • Veritable's iShares Global Healthcare ETF position peaked at $816K in Q4 2021.
  • 271 funds tracked by Wall St. Rank held iShares Global Healthcare ETF as of Q2 2023.

Based on Veritable's 13F filing for Q2 2023, filed 9 Aug 2023.